TrialBMC medicine2024

Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial.

Sai Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.